- Investing Ideas
- /
- Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Results
5
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
5 companies
MicroPort CardioFlow Medtech
Market Cap: HK$2.7b
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.
2160
HK$1.11
7D
-6.7%
1Y
52.1%
Shanghai Conant Optical
Market Cap: HK$23.8b
Manufactures and sells resin spectacle lenses in Mainland China, the Americas, Asia, Europe, Oceania, and Africa.
2276
HK$49.68
7D
10.4%
1Y
246.9%
MicroPort NeuroScientific
Market Cap: HK$6.3b
Provides neuro-interventional medical devices.
2172
HK$11.02
7D
-7.0%
1Y
11.0%
Zylox-Tonbridge Medical Technology
Market Cap: HK$7.6b
A medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally.
2190
HK$23.46
7D
-0.8%
1Y
112.5%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$6.4b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease.
2291
HK$18.32
7D
-2.6%
1Y
3.0%